| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30beaaa993ebfd38cfa2df185ff97bb6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2006-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e08e262703a86d92797f9f199602c5f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a1e58e9efe3cb6bfc4016359c5072e0 |
| publicationDate |
2009-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101346132-A |
| titleOfInvention |
Crystalline pyrimidine nucleoside derivatives suspensions in capsules |
| abstract |
The present invention relates to a pharmaceutical formulation which comprises (i) a capsule, and (ii) a core comprising crystalline 2'-cyano-2'-deoxy-N<4>-palmitoyl-l-ss-D-arabinofuranosylcytosine and a liquid carrier. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102414216-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106963742-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102414216-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106963742-A |
| priorityDate |
2005-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |